Back to Trades
Sell4
QUEST DIAGNOSTICS INC
DGX
Total Value
$21.1M
Net $10.6M sold
Sales
$10.6M
3 transactions
Company Information
- Company Name
- QUEST DIAGNOSTICS INC
- Ticker Symbol
- DGX
- CIK
- 0001022079
Insider Information
- Name
- Davis J. E.
- Role
- CEO and President, Director
- Location
- SECAUCUS, NJ
DirectorOfficer
Filing Details
- Filing Date
- Nov 28, 2025
- Transaction Date
- Nov 25, 2025
- Accession Number
- 0001022079-25-000233
- Form Type
- 4
- Net Trading Amount
- -$10.6M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Nov 25, 2025 | Common Stock | 55,093 | $95.79 | Exercise | $5.3M |
| Nov 25, 2025 | Common Stock | 9,342 | $191.59 | Sale | $1.8M |
| Nov 25, 2025 | Common Stock | 41,004 | $192.27 | Sale | $7.9M |
| Nov 25, 2025 | Common Stock | 4,747 | $192.97 | Sale | $916.0K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Nov 25, 2025 | Derivative | 55,093 | $95.80 | Exercise | $5.3M |
Footnotes
- (F1)This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
- (F2)This transaction was executed in multiple trades at prices ranging from $190.810 to $191.805. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F3)This transaction was executed in multiple trades at prices ranging from $191.820 to $192.810. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F4)This transaction was executed in multiple trades at prices ranging from $192.820 to $193.310. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F5)The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.